Rosen, Raymond C.
Stephens-Shields, Alisa J.
Cunningham, Glenn R.
Cifelli, Denise
Cella, David
Farrar, John T.
Barrett-Connor, Elizabeth
Lewis, Cora E.
Pahor, Marco
Hou, Xiaoling
Snyder, Peter J.
Funding for this research was provided by:
National Institute on Aging (U01 AG030644, R01 AG037679, P30AG028740, AG028507, U01 AG030644, U01 AG030644, U01 AG030644, U01 AG030644, U01 AG030644)
National Institute of Diabetes and Digestive and Kidney Diseases (DK079626, DK031801)
National Institute on Aging (U01 AG030644, U01 AG030644)
Article History
Accepted: 4 September 2015
First Online: 10 September 2015
Compliance with ethical standards
:
: GRC has served as a consultant to AbbVie, Clarus Therapeutics, Endo Pharma, Ferring, Lilly, Repros Therapeutics, and he has served as an expert witness for Repros Therapeutics and Solvay. He has received research support from Ardana, Unimed and Abbvie; CEL was supported by the National Institute for Diabetes, Digestive and Kidney Diseases, National Institutes of Health (DK079626) to the UAB Diabetes Research and Training Center; PJS reports grants from NIH and AbbVie for the conduct of this study; remaining authors report no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.